HOUSTON--(BUSINESS WIRE)--ThromboVision, Inc., a Houston-based biomedical diagnostics company, has closed on a tranche of $400,000 in Series A financing from private investors. The company will use the investment to fund clinical trials, build its infrastructure, and advance the FDA approval process for its ThromboGuide® platelet function monitor system.
